Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection.
about
Treatment of hepatocellular carcinoma: Steps forward but still a long way to goGuide for diagnosis and treatment of hepatocellular carcinoma2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaManagement strategies for hepatocellular carcinoma: old certainties and new realities.Advances in non-surgical management of primary liver cancer.Thermal ablation of hepatocellular carcinoma.Percutaneous ablation for small hepatocellular carcinoma.Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinomaInitial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Risk factors for residual tumor after resection of hepatocellular carcinoma.Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial.Management of hepatocellular carcinoma: Enlightening the gray zones.Combining locoregional therapies in the treatment of hepatocellular carcinoma.Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in KoreaHigh-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicitiesPreoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.Hepatocellular carcinoma: new options for image-guided ablation.Loco-regional treatment of hepatocellular carcinoma.Prognostic factors for hepatocellular carcinoma recurrence.An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip radiofrequency ablation system.Ethanol injection therapy for small hepatocellular carcinomas located beneath a large vessel using a curved percutaneous ethanol injection therapy needle.Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis.Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis.Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Biomarkers for hepatocellular carcinoma.131I lipiodol therapy for unresectable hepatocellular carcinoma.
P2860
Q26865456-55382756-45D4-48FA-A3F3-28CE1BA7BEB4Q28084003-B31B6D8F-6E7E-4B68-A7CA-1DDB5DCE9F13Q28392783-5A70FB74-7DE0-4876-82D7-156A5030A91FQ28394414-2165735A-19DA-44BE-ABE5-3666FE625750Q30252143-45E44738-542C-4FFC-87FD-3FC3EAFBF34AQ30423781-D48EB3FF-055F-4A9D-818A-72E13757DEB0Q33323261-3FB129AE-9C9F-4CD7-9C8D-C8CD1C120F57Q33427579-BFC8820B-2865-43BA-947C-9584D1A385C1Q34332296-B72C093F-6D9E-4A8F-9BE6-8E1628FD78D4Q34552875-1EDB42DB-586C-4461-A633-33224EF1D2A4Q34826535-BFEB5697-2E2F-4FC6-90DC-B25547A6C6B2Q34831310-758F5D27-23FB-4397-907F-F7DF0C96ED19Q35273624-DFB8DEA7-12BE-4C72-84E2-4E0511CC3194Q36955647-DCBEF28F-B4FA-4615-BB21-10C4729A941DQ36980629-6341D707-DA10-425F-8639-609C75A14914Q37155074-DB613953-B710-4A8C-B392-73042411E19AQ37269624-CE2932E2-12FF-4890-B2F5-FD617960CD5AQ37568646-BEE94905-C79F-4825-85BF-A7B9FDF0E2DEQ37678972-7781C615-127A-4AF9-A926-10E399DC5C93Q37766546-AC82B9A2-C72E-4D52-A352-E670914ACD55Q38216004-B2E77479-62C2-4130-82AD-0470124D8578Q38371669-A5DB1202-C22B-42E8-B8BD-3FA7934245EAQ40150833-8ADA8A32-3B92-433F-9CF3-5B9C1436DA60Q40452297-4AFEE0AD-DF15-46AE-9CDF-DDC3CA42AEA5Q42793211-1E611587-EC1A-41CC-B5F1-6A972F42B744Q43806466-674ACC88-1065-4C34-BD93-901E8985C832Q44105262-679969E1-7C98-4D20-98B1-2524F23BF957Q45340189-0CB0348C-58E9-49D7-8D70-C86792177CDDQ49627939-E49CF245-D2F5-49D9-A3DA-118E1F8CACCFQ51595454-E75A1AE3-6489-4E2D-8FA9-55EC37B48B29Q53430498-F287326B-B780-482D-8F34-B262A410A957
P2860
Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prospective analysis of risk f ...... a following ethanol injection.
@ast
Prospective analysis of risk f ...... a following ethanol injection.
@en
Prospective analysis of risk f ...... a following ethanol injection.
@nl
type
label
Prospective analysis of risk f ...... a following ethanol injection.
@ast
Prospective analysis of risk f ...... a following ethanol injection.
@en
Prospective analysis of risk f ...... a following ethanol injection.
@nl
prefLabel
Prospective analysis of risk f ...... a following ethanol injection.
@ast
Prospective analysis of risk f ...... a following ethanol injection.
@en
Prospective analysis of risk f ...... a following ethanol injection.
@nl
P2093
P1476
Prospective analysis of risk f ...... a following ethanol injection.
@en
P2093
Yamasaki K
Yamasaki M
Yatsuhashi H
P304
P356
10.1016/S0168-8278(00)80072-0
P577
2000-02-01T00:00:00Z